We studied 41 eyes of 41 volunteers seen at Shinanozaka Clinic and Wada Eye Clinic (12 men, 29 women; mean age: 45.1 ± 9.4 years; age range, 23–57 years), with normal tear function and ocular surface except for tear stability (specifically, BUT ≤5 seconds; Schirmer test >5 mm; and keratoconjunctival vital staining score <3 points). Eyes were divided into two groups depending on the presence or absence of DE symptoms: the symptomatic group comprised 21 eyes of 21 subjects with DE symptoms (3 men, 18 women; mean age: 45.7 ± 8.5 years; age range, 28–57 years), and the asymptomatic group comprised 20 eyes of 20 subjects without DE symptoms (9 men, 11 women; mean age: 43.5 ± 9.5 years; age range, 23–57 years). When both eyes were affected, the right eye was studied. To avoid bias caused by age-related decrease in corneal sensitivity, we recruited only subjects younger than 60 years. Subjects were excluded from the study if they had a history of ocular trauma, ophthalmic surgery, ophthalmic diseases other than DE, contact lens use, or daily ophthalmic solution use.
This research followed the Tenets of the Declaration of Helsinki. Informed consent was obtained from all subjects after explanation of the nature and possible consequences of the study. Ethics committee approval for the examination procedures and study protocol was obtained from the institutional review board of Shinanozaka Clinic, Tokyo.